Abstract

Aurobindo Pharma Limited, a leading Indian pharmaceutical company is ranked among the top 10 generic pharma companies in the world. It is an integrated large global pharmaceutical company with a presence in over 155 countries, with planned expansion into new territories such as Poland, Italy, Spain, the Czech Republic, Portugal, and France. Aurobindo Pharma became a public listed company in 1992. As of 2024, its market capitalization was US$ 8,565 million. The management of the company initiated several measures to transform business operations to meet the ever changing market dynamics in India and across the globe. Of the major objectives Aurobindo Pharma planned to achieve during the fiscal year 2024-25, improving its operational performance was a key short-term one. The present case study helps in assessing the trend in the operational performance of Aurobindo Pharma using profitability ratios.

Learning Objectives

The case is structured to achieve the following Learning Objectives:

• The process of analyzing and interpreting the profitability position of a company.
• The difference between various profitability ratios.
• The profitability position of Aurobindo Pharma Limited.

Keywords

Profitability; Aurobindo Pharma; Operating Performance; Gross profit; Net profit